Komori
Leoclan (7681) · RiskRestatedLatest Financial Results Presentation (2026-08-07): "Worsened"

Fluctuations in demand for new construction, relocation, and expansion or renovation of medical facilities

First written in FY2021. 10 of 13 entries say "Restated". Latest entry: 2026-08-07.

13entries
6years
2from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY20252021: 12022: 220222023: 320232024: 320242025: 220252026: 22026
Same theme, other companies

Leoclan moved to the "Worse" side of this theme in 2026.

0 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「Demand for relocation, new construction, expansion and renovation projects at medical institutions and other facilities may fluctuate from year to year depending on healthcare administration, healthcare budgets, construction costs and other factors, causing the number of large-scale projects won and the Company's performance to fluctuate.」

    The risk of fluctuations in demand for large-scale medical facility projects due to trends in healthcare administration, healthcare budgets and construction costs continues.
  2. FY2025-H1RestatedAnnual report

    「During the interim consolidated accounting period, there were no new occurrences of major risks that management recognizes could materially affect the financial position, operating results or cash flows of the consolidated companies among the matters concerning business conditions and financial matters described in this interim report, nor any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」

    The company concluded that there had been no material change in the risk of fluctuations in demand for new construction, relocation, expansion and renovation of medical facilities.
  3. FY2024RestatedAnnual report

    「Demand for relocation, new construction, expansion and renovation projects at medical institutions and other facilities may fluctuate from year to year depending on healthcare administration, healthcare budgets, construction costs and other factors, causing the number of large-scale projects won and the Company's performance to fluctuate.」

    The risk of fluctuations in demand for large-scale medical facility projects due to trends in healthcare administration, healthcare budgets and construction costs continues.
  4. FY2024-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company concluded that there had been no material change in the risk of fluctuations in demand for new construction, relocation, expansion and renovation of medical facilities.
  5. FY2024-Q1RestatedAnnual report

    「During the cumulative first quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company concluded that there had been no material change in the risk of fluctuations in demand for new construction, relocation, expansion and renovation of medical facilities.
  6. FY2023RestatedAnnual report

    「Demand for relocation, new construction, expansion and renovation projects at medical institutions and other facilities may fluctuate from year to year depending on healthcare administration, healthcare budgets, construction costs and other factors, causing the number of large-scale projects won and the Company's performance to fluctuate.」

    The risk of fluctuations in demand for large-scale medical facility projects due to trends in healthcare administration, healthcare budgets and construction costs continues.
  7. FY2023-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company concluded that there had been no material change in the risk of fluctuations in demand for new construction, relocation, expansion and renovation of medical facilities.
  8. FY2023-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company concluded that there had been no material change in the risk of fluctuations in demand for new construction, relocation, expansion and renovation of medical facilities.
  9. FY2022-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company concluded that there had been no material change in the risk of fluctuations in demand for new construction, relocation, expansion and renovation of medical facilities.
  10. FY2022-Q1RestatedAnnual report

    「During the cumulative first quarter of the current consolidated fiscal year, there were no material changes in the occurrence of major risks that management recognizes could materially affect the financial position, operating performance or cash flows of the consolidated companies, among the matters concerning the business and accounting conditions described in the quarterly report, or in the business and other risks described in the annual securities report for the previous fiscal year.」

    The company concluded that there had been no material change in the risk of fluctuations in demand for new construction, relocation, expansion and renovation of medical facilities.
  11. FY2021First statedAnnual report

    「Demand for relocation, new construction, expansion and renovation projects at medical institutions and other facilities may fluctuate from year to year depending on healthcare administration, healthcare budgets, construction costs and other factors, causing the number of large-scale projects won and the Company's performance to fluctuate.」

    The company separately identifies the risk that demand for large-scale medical facility projects may fluctuate, causing orders to rise or fall, depending on healthcare administration, healthcare budgets and construction costs.
Moved together

"Losses in the Medical Total Solutions Business Due to Low-Margin Bulk Sales and Replacement Projects" moved the same way as this thread, in the same document, in 2 of its 13 moves.

2★1
  1. ★This thread
  2. 1Losses in the Medical Total Solutions Business Due to Low-Margin Bulk Sales and Replacement Projects2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Leoclan yet. It last moved in the Financial Results Presentation of 2026-08-07: "Worsened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Fluctuations in demand for new construction, relocation, and expansion or renovation of medical facilities | LEOCLAN Co.,Ltd. (7681) | Komori